Form 13-F position report

DARE BIOSCIENCE INC COM

Reported by PNC FINANCIAL SERVICES GROUP INC

DARE CUSIP 23666P101 Manager CIK 0000713676

Reported 0 shares, down 3,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 13 Through Q3 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 5000
2022-03-31 4000
2022-06-30 4000
2022-09-30 4000
2022-12-31 3652
2023-03-31 4576
2023-06-30 4004
2023-09-30 2033
2023-12-31 1360
2024-03-31 2156
2024-06-30 1008
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for DARE BIOSCIENCE INC COM held by PNC FINANCIAL SERVICES GROUP INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -3,000 (-100.0%) 0 $0 2024-11-08
Q2 2024 Reduced 3,000 -1,400 (-31.8%) < 0.01% $1,008 2024-08-09
Q1 2024 Unchanged 4,400 0 (0.0%) < 0.01% $2,156 2024-05-10
Q4 2023 Unchanged 4,400 0 (0.0%) < 0.01% $1,360 2024-02-09
Q3 2023 Unchanged 4,400 0 (0.0%) < 0.01% $2,033 2023-11-13
Q2 2023 Unchanged 4,400 0 (0.0%) < 0.01% $4,004 2023-08-11
Q1 2023 Unchanged 4,400 0 (0.0%) < 0.01% $4,576 2023-05-15
Q4 2022 Unchanged 4,400 0 (0.0%) < 0.01% $3,652 2023-02-10
Q3 2022 Added 4,400 +1,000 (29.4%) < 0.01% $4,000 2022-11-10
Q2 2022 Added 3,400 +1,000 (41.7%) < 0.01% $4,000 2022-08-12
Q1 2022 Unchanged 2,400 0 (0.0%) < 0.01% $4,000 2022-05-12
Q4 2021 Added 2,400 +1,000 (71.4%) < 0.01% $5,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

24 managers reported DARE BIOSCIENCE INC COM for Q3 2024.

Managers reporting DARE BIOSCIENCE INC COM in Q3 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Raymond James Financial Services Advisors Inc Reduced 0 -20,000 0 $0 12 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 0 -20,000 0 $0 19 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 0 -25,947 0 $0 11 qtrs
TWO SIGMA SECURITIES LLC Reduced 0 -102,896 0 $0 5 qtrs
STATE STREET CORPORATION Reduced 0 -282,210 0 $0 14 qtrs
NORTHERN TRUST CORPORATION Reduced 0 -185,485 0 $0 26 qtrs
Tower Research Capital LLC TRC Reduced 0 -15,302 0 $0 18 qtrs
WEALTH ENHANCEMENT ADVISORY SERVICES LLC Reduced 0 -30,875 0 $0 4 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Reduced 0 -30,532 0 $0 15 qtrs
COMMONWEALTH EQUITY SERVICES LLC Reduced 0 -45,925 0 $0 15 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2024
Filed
November 08, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.